American Oncology Network Partners with Evolent to Eliminate Prior Authorization in Cancer Care

Reuters

Nov 07, 2025

<a href="https://laohu8.com/S/AONC">American Oncology Network</a> Partners with Evolent to Eliminate Prior Authorization in Cancer Care

American Oncology Network Inc. $(AON)$ and Evolent Health, Inc. have announced a new national partnership aimed at improving cancer care delivery. The collaboration introduces an innovative model designed to provide high-quality, more affordable, and connected cancer care without the need for prior authorization. Key components of the program include quality initiatives to enhance care across the continuum, the use of provider education and incentives, and AI-driven clinical insights powered by the MiBA data and analytics platform. Providers demonstrating adherence to quality standards will be "gold-carded," exempting them from most prior authorization requirements. The partnership also seeks to support patients through enhanced care navigation and connectivity with their oncology teams, with the model set to roll out in select markets in the coming year.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. American Oncology Network Inc. published the original content used to generate this news brief on November 06, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2581045550"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2581045550\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2581045550?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-07 05:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2581045550","market":"us","top_or_hot":-1,"title":"American Oncology Network Partners with Evolent to Eliminate Prior Authorization in Cancer Care","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/AONC\">American Oncology Network</a> Partners with Evolent to Eliminate Prior Authorization in Cancer Care\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/AONCW\">American Oncology Network</a> Inc. <a href=\"https://laohu8.com/S/AON\">$(AON)$</a> and <a href=\"https://laohu8.com/S/EVH\">Evolent Health</a>, Inc. have announced a new national partnership aimed at improving cancer care delivery. The collaboration introduces an innovative model designed to provide high-quality, more affordable, and connected cancer care without the need for prior authorization. Key components of the program include quality initiatives to enhance care across the continuum, the use of provider education and incentives, and AI-driven clinical insights powered by the MiBA data and analytics platform. Providers demonstrating adherence to quality standards will be \"gold-carded,\" exempting them from most prior authorization requirements. The partnership also seeks to support patients through enhanced care navigation and connectivity with their oncology teams, with the model set to roll out in select markets in the coming year.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. American Oncology Network Inc. published the original content used to generate this news brief on November 06, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>American Oncology Network Partners with Evolent to Eliminate Prior Authorization in Cancer Care</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmerican Oncology Network Partners with Evolent to Eliminate Prior Authorization in Cancer Care\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-07 05:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/AONC\">American Oncology Network</a> Partners with Evolent to Eliminate Prior Authorization in Cancer Care\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/AONCW\">American Oncology Network</a> Inc. <a href=\"https://laohu8.com/S/AON\">$(AON)$</a> and <a href=\"https://laohu8.com/S/EVH\">Evolent Health</a>, Inc. have announced a new national partnership aimed at improving cancer care delivery. The collaboration introduces an innovative model designed to provide high-quality, more affordable, and connected cancer care without the need for prior authorization. Key components of the program include quality initiatives to enhance care across the continuum, the use of provider education and incentives, and AI-driven clinical insights powered by the MiBA data and analytics platform. Providers demonstrating adherence to quality standards will be \"gold-carded,\" exempting them from most prior authorization requirements. The partnership also seeks to support patients through enhanced care navigation and connectivity with their oncology teams, with the model set to roll out in select markets in the coming year.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. American Oncology Network Inc. published the original content used to generate this news brief on November 06, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AONC","symbol_name":"American Oncology Network, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL9lY7WP:1","article_id":"2581045550","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2581045550","pubTimestamp":1762465287,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"American Oncology Network Inc.  and Evolent Health, Inc. have announced a new national partnership aimed at improving cancer care delivery. The collaboration introduces an innovative model designed to provide high-quality, more affordable, and connected cancer care without the need for prior authorization. Key components of the program include quality initiatives to enhance care across the continuum, the use of provider education and incentives, and AI-driven clinical insights powered by the MiBA data and analytics platform. Providers demonstrating adherence to quality standards will be \"gold-carded,\" exempting them from most prior authorization requirements. The partnership also seeks to support patients through enhanced care navigation and connectivity with their oncology teams, with the model set to roll out in select markets in the coming year.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accu","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"AONC":"American Oncology Network, Inc.","BK4167":"医疗保健技术","EVH":"Evolent Health Inc","BK4196":"保健护理服务","LU0053671581.USD":"摩根大通美国小盘成长股 A(dist)"},"translate_title":"美国肿瘤网络与Evolent合作取消癌症护理的事先授权","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AONC":0.9,"EVH":0.9},"content_text":"American Oncology Network Partners with Evolent to Eliminate Prior Authorization in Cancer Care\n    \n\nAmerican Oncology Network Inc. $(AON)$ and Evolent Health, Inc. have announced a new national partnership aimed at improving cancer care delivery. The collaboration introduces an innovative model designed to provide high-quality, more affordable, and connected cancer care without the need for prior authorization. Key components of the program include quality initiatives to enhance care across the continuum, the use of provider education and incentives, and AI-driven clinical insights powered by the MiBA data and analytics platform. Providers demonstrating adherence to quality standards will be \"gold-carded,\" exempting them from most prior authorization requirements. The partnership also seeks to support patients through enhanced care navigation and connectivity with their oncology teams, with the model set to roll out in select markets in the coming year.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. American Oncology Network Inc. published the original content used to generate this news brief on November 06, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}